Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.6K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unstable Plaque is a Treatable Cause of Cognitive Decline.

Medical hypotheses·2024
Same author

Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022
Same author

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study.

Journal of neurology·2019
Same author

Prevalence of Previously Undiagnosed Abdominal Aortic Aneurysms in Patients with Intracranial Aneurysms: From the Brain and Aortic Aneurysms Study (BAAS).

Neurocritical care·2019
Same author

Stroke-related epilepsy.

European journal of neurology·2018
Same author

Every physician should discourage cigarette smoking.

European journal of neurology·2018
Same journal

Blood Pressure Control With Clevidipine Is Associated With Hematoma Volume Reduction in Acute Hypertensive Intracerebral Hemorrhage: A Single-Center Prospective Cohort Study.

European journal of neurology·2026
Same journal

CGRP-Targeted Therapy in Vestibular Migraine-How Strong Is the Evidence?

European journal of neurology·2026
Same journal

Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation.

European journal of neurology·2026
Same journal

Pharmacological Treatment of Cerebellar Ataxia in Pediatric Ataxia-Telangiectasia: A Systematic Review.

European journal of neurology·2026
Same journal

Intensive Rehabilitation With Adjunctive Bilateral Anodal tDCS in Post-Stroke Dysphagia: A Multicenter Randomized Controlled Trial.

European journal of neurology·2026
Same journal

Distal Agrin (AGRN) Congenital Myasthenic Syndrome With Mitochondrial Dysfunction.

European journal of neurology·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

3.1K

Ischaemic stroke.

J F Meschia1, T Brott1

  • 1Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.

European Journal of Neurology
|August 12, 2017
PubMed
Summary
This summary is machine-generated.

Worldwide, 25.7 million people live with stroke. Ischaemic stroke, the most common type, is increasingly treatable with new medical and endovascular therapies aimed at reducing brain damage and improving recovery.

Keywords:
cerebrovascular diseases and cerebral circulationneurological disordersstroke

More Related Videos

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat
13:50

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Published on: February 5, 2011

81.0K
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

36.3K

Related Experiment Videos

Last Updated: Feb 24, 2026

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

3.1K
Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat
13:50

Focal Cerebral Ischemia Model by Endovascular Suture Occlusion of the Middle Cerebral Artery in the Rat

Published on: February 5, 2011

81.0K
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

36.3K

Area of Science:

  • Neurology
  • Public Health

Background:

  • Ischaemic stroke is the predominant type of stroke, affecting millions globally.
  • Established risk factors include lifestyle behaviors (smoking, inactivity) and medical conditions (hypertension, hyperlipidemia, atrial fibrillation).

Purpose of the Study:

  • To review the current understanding and management of ischaemic stroke.
  • To highlight advances in acute treatment and future directions in stroke prevention and recovery.

Main Methods:

  • Literature review of epidemiological data and therapeutic advancements in ischaemic stroke.
  • Analysis of modifiable risk factors and current treatment modalities.

Main Results:

  • Acute ischaemic stroke, once deemed irreversible, can now be treated with medical and endovascular interventions to minimize infarct size.
  • Significant progress has been made in identifying and managing risk factors.

Conclusions:

  • Effective management of modifiable risk factors is crucial for stroke prevention.
  • Emerging therapies offer improved outcomes for acute ischaemic stroke and hold promise for enhanced recovery.